Matricelf Reports 2025 Milestones, 2026 Spinal Implant Roadmap
Matricelf Ltd. (TASE: MTLF), a biotechnology company developing personalized regenerative therapies for spinal cord injury, today issued a shareholder update summarizing its 2025 achievements and...